By David Garner – This is Nurses Week and we are highlighting challenges and issues facing our nursing professionals. Can analytics and AI help with today’s challenges? Garner says yes as he identifies some of the top issues.
Read More
By Dmitrii Evstiukhin – Medical insurance claims processes create mounds of documents that often get backlogged or denied, slowing business operations and reducing efficiency. Now AI solutions are dramatically accelerating medical claims processing while reducing errors and enhancing overall efficiency.
By Jim Tate – I attended the recent HIMSS conference in Chicago with a particular interest in finding out what is going on with the TEFCA. This interoperability initiative, more than six years in the making, appears to be close to bearing fruit. My observations are based on conversations with pending QHINs, TEFCA presentations, and a little eavesdropping.
By Alena Nikuliak – Telehealth technology is centered around the development of apps and software. Healthcare organizations can choose to build custom telemedicine apps or choose a SaaS telehealth provider.
By Patrick Cronin – Cancer is a condition that’s affected most people in one way or another, and finding ways to treat it has been the focus of the world’s top scientists and oncologists for decades. Researchers are making major breakthroughs using the power of data science.
By Gimmy Chen – It’s not big news that the life sciences and pharmaceutical industries are data-intensive but the the scale and scope of data analytics may still surprise people. The data volumes are immense. Data analytics is central to their main strategic and profit-making workloads.
By Katie Brenneman – To be sure, telehealth did not begin with the COVID-19 pandemic, nor will it end with it. Indeed, virtual patient care has been evolving for years, emerging alongside the ascendency of the digital revolution in other domains, from shopping to education.
By Devin Partida – IT professionals in every sector have a duty to accelerate technological innovation. Medtech is a unique industry rife with outdated tools while being the most desperate for advancement to meet a growing population’s increasingly complex health needs.
By Tom Dorsett – As of April 2023, the FDA has approved the use of 40 “biosimilars”, which are a less expensive version of an advanced “biologic” medication. The rise of biosimilars is a major source of excitement as a way to control rising drug costs. But is the fervor warranted?